Yildiz H, Van Den Neste E, Defour JP, Danse E, Yombi JC (January 2020). “Adult haemophagocytic lymphohistiocytosis: a Review”. 《QJM》 115 (4): 205–213. doi:10.1093/qjmed/hcaa011. PMID31943120.
Hande KR (1998). “Etoposide: four decades of development of a topoisomerase II inhibitor”. 《Eur. J. Cancer》 34 (10): 1514–21. doi:10.1016/S0959-8049(98)00228-7. PMID9893622.
Gordaliza M, García PA, del Corral JM, Castro MA, Gómez-Zurita MA (2004). “Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives”. 《Toxicon》 44 (4): 441–59. doi:10.1016/j.toxicon.2004.05.008. PMID15302526.
World Health Organization (2019). 《World Health Organization model list of essential medicines: 21st list 2019》. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
nih.gov
ncbi.nlm.nih.gov
Yildiz H, Van Den Neste E, Defour JP, Danse E, Yombi JC (January 2020). “Adult haemophagocytic lymphohistiocytosis: a Review”. 《QJM》 115 (4): 205–213. doi:10.1093/qjmed/hcaa011. PMID31943120.
Hande KR (1998). “Etoposide: four decades of development of a topoisomerase II inhibitor”. 《Eur. J. Cancer》 34 (10): 1514–21. doi:10.1016/S0959-8049(98)00228-7. PMID9893622.
Gordaliza M, García PA, del Corral JM, Castro MA, Gómez-Zurita MA (2004). “Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives”. 《Toxicon》 44 (4): 441–59. doi:10.1016/j.toxicon.2004.05.008. PMID15302526.
web.archive.org
“Etoposide”. The American Society of Health-System Pharmacists. 2016년 3월 31일에 원본 문서에서 보존된 문서. 2016년 12월 8일에 확인함.